THE INVESTOR'S DESK
SPY +0.67%QQQ +0.88%IWM +0.66%
MARKET CLOSED

VRTX

Vertex Pharmaceuticals IncQuiet & expensive
$503.50-1.23 ▼ -0.24%Oct 5, 4:00 PM ET
OptionsPaper trade
Target price$362.00by DCF28.1% below the price
Crowd score30/100Crowd-driven · 0 confirming
Sentiment0.00FinBERT, −1 to +1
Mentions · 24h0▲ +0% vs 7-day avg

Price × crowd

1M3M1Y5Y
400450500TARGET 362.00Jul 25, 2026Aug 25, 2026Sep 25, 2026

Why this score

2 sources

Each part compares today with this ticker's own last 60 trading days. The centre line is normal.

  • Attention 35%+0.7σ
  • Opinion 35%no data yet—
  • Breadth 15%no data yet—
  • Momentum 15%+0.6σ
Wikipedia +0.7σHeadlines −0.9σ
Sources confirming
0
Driven by
The crowd (no big news)

Herd behaviour

score, last year
060100NovJanMarMayJulSep
Hype gap+1.5σCrowd and news are roughly in step.
Fades in1 dayBursts of attention halve quickly: fads come and go.
Talk vs pricemove −0.6σToday's price move compared with the last 60 days.
StreaknoneTrading days in a row at a score of 60 or more.

What the crowd is saying

24h

No narratives for VRTX yet. They come from what people post (Bluesky, Hacker News, and Reddit once connected).

All narratives on Crowd →

Valuation

drag to change
Target priceDCF$362.0028.1% below today's price of $503.50
FILINGS TO 2026-06-30

Discounted cash flow. Valued on free cash flow: what the business generates for everyone who funds it.

9.63%
Fades to terminal growth by year 10 · starts at 9.63%
22.9%
Share of revenue left as cash · starts at 22.88%
7.61%
What all investors demand each year · starts at 7.61%
2.50%
Forever, after year 10 · starts at 2.50%
How the value adds up
10 years of free cash flow, today's value$28.3B
+Everything after year 10$49.8B
Business value (EV)$78.1B
+Cash and investments$13.6B
−Debt and minority interests$0.00
Owners' value$91.8B
÷Shares0.25B
Per share$362.00
64% of the value comes after year 10.
If the rates were different
WACC ↓ g →1.5%2.0%2.5%3.0%3.5%
6.6%373403439486548
7.1%343367397433479
7.6%319338362391426
8.1%298314334357385
8.6%280294310329352
Rows: WACC. Columns: terminal growth. Centre = your settings. Green = above today's price.
The 10-year projection
Year12345678910
Growth9.6%8.8%8.0%7.3%6.5%5.7%4.9%4.1%3.3%2.5%
Revenue$13.8B$15.0B$16.2B$17.4B$18.5B$19.6B$20.5B$21.4B$22.1B$22.6B
Free cash flow$3.2B$3.4B$3.7B$4.0B$4.2B$4.5B$4.7B$4.9B$5.1B$5.2B
Worth today$2.9B$3.0B$3.0B$3.0B$2.9B$2.9B$2.8B$2.7B$2.6B$2.5B
Where the starting numbers come from
Revenue, last 12 months
$12.6B
Revenue growth: 3-yr avg / last yr
10.4% / 8.9%
FCF margin: last 12 mo / 3-yr median
24.8% / 21.0%
Risk-free rate
5.28%
Beta (Finnhub, adjusted toward 1)
0.52
Stock premium over Treasuries
4.5%
Cost of equity = rf + β × premium
7.6%
Cost of debt (before tax)
6.8%
Tax rate
16.5%
Equity share of funding
100%

Free cash flow = operating cash flow − capital spending − stock-based pay + after-tax interest. Growth starts at the average of the 3-year and last-year rates; the margin is the average of the last 12 months and the 3-year median.

SEC EDGAR XBRL · Risk-free: 10-year Treasury, 2026-10-02 · Beta: Finnhub, adjusted toward 1 · debt_long not reported on the latest balance sheet; treated as 0 · minority_interest not reported on the latest balance sheet; treated as 0

Key stats

Market cap$131.2B
P/E (TTM)29.8
Gross margin86.0%
Operating margin38.0%
52-week range$400.74 – $560.25
Avg volume (10 days)1000K
Beta0.28

From Finnhub, updated a few times a day.